This pilot RCT will examine the preliminary efficacy of a telehealth version of Mindfulness-Oriented Recovery Enhancement (MORE) enriched with a smartphone-based just-in-time adaptive intervention (JITAI) for patients with chronic pain on long-term opioid therapy. Read [...]
The Federation of State Medical Boards is holding ongoing meetings with its member boards to discuss how the COVID-19 pandemic is impacting the mental health of clinicians and to further address ways in which licensing [...]
Diverse cognitive strategies affect our perception of pain. Studies by Ludwig-Maximilians-University München (Germany) neuroscientist Enrico Schulz and colleagues have linked the phenomenon to the coordinated activity of neural circuits located in different brain areas. Full [...]
The study aimed to explore the potential relationship between the clinical efficacy of eMCS for the treatment of chronic neuropathic pain and the precise localization of the contacts over the motor cortex somatotopic representation of [...]
This project is focused on Veteran patients 65 and older with chronic pain. In this project, the investigators will understand the impact of a contextual patient generated data (PGD). Contextual PGD are data about what [...]
The brainstem has become of ever more interest in chronic fatigue syndrome (ME/CFS). Full story.
Intravenous (IV) ibuprofen adequately relieved acute pain and minimized opioid use in the first 48 hours after an orthopedic trauma, a trial in the Journal of Orthopaedic Trauma reported. Full story.
The elderly in the United States report less pain than those in midlife—suggesting, perhaps, that once people move into old age, their morbidity will fall. Unfortunately, assessing pain by age at one point in time [...]
Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced the publication of a new real-world post-marketing surveillance study in Pain Medicine that demonstrates the safety, efficacy and [...]
Molecules from the venom of one of the world's largest spiders could help University of Queensland-led researchers tailor pain blockers for people with irritable bowel syndrome (IBS). Full story.
© American Academy of Pain Medicine. All Rights Reserved | Privacy Policy | Media Resources
American Academy of Pain Medicine (AAPM) is a nonprofit 501(c)(6) tax-exempt organization.
